Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer

Is the pandemic interfering with the treatment for other diseases?

NEIGRIHMS Life Science Project Manager Recruitment | Applications Invited

Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer
  • BiotechToday
  • World

Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer

bioxone October 20, 2020October 19, 2020

Biswadeep Sen, Amity University Kolkata

Recent studies show that Inflammation and Carcinogenic processes are interconnected. Not just because both induce DNA instability, but both are driven by the same pathways (like NF-kB, STAT3, mTOR and MAPKs). 

The pro-inflammatory cytokines like IL-6, IL-1β, TNF-α and IL-10 mould our immune responses and they are controlled by the pathways mentioned above. Therefore, they can be considered as a double-edged sword, responsible for both our protection and if went wrong, or destruction.  Now, these pathways often trigger the UPR which is responsible for cells to survive stress and is initiated by three cellular sensors. These sensors can also trigger the oncogenic pathways leading to malignancy of tumours. UPR is activated whenever an unfolded protein finds itself inside the ER and via autophagy, it helps to eliminate the misfolded proteins. So, we can safely assume that any regulatory problem about it, might trigger a host of diseases including cancer. 

Studies have pointed out that ATF6, one of the three sensors of UPR, activated by a mutp53 May contribute to a p38 phosphorylation making it possible for counteracting the autophagy.   On the other hand, NF-KB, which is reported to inhibit autophagy, might also be activated by ARF6 and induced by a mutp53. This could contribute to its sustainability of expression level and inhibition of Autophagy. 

Therefore, interrupting such interplay between UPR and the oncogenic pathways may affect the pre oncogenic inflammation and stability of a mutp53 and downregulation of them might break the bridge between inflammation and cancer. Several Inhibitors like WP1066 or LY3007113 are used alone or in combination so that they can interfere with the aspects of carcinomic biology. 

Also read: Efficient and cost-effective Bacterial mRNA sequencing causing ribosomal RNA depletion

Source: D’Orazi, G., Cordani, M. & Cirone, M. Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: a clue for novel anticancer therapies. Cell. Mol. Life Sci. (2020). https://doi.org/10.1007/s00018-020-03677-7

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Autophagy Carcinogen DNA instability folding immunology inflammation inhibitor interleukins malignancy metastasis modulator oncogenic pathways oncology protein folding stereochemistry

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

NEIGRIHMS Life Science Project Manager Recruitment | Applications Invited

bioxone October 20, 2020

-Shristi Sharma, Team bioXone NEIGRIHMS Life Science Project Manager Recruitment – Applications Invited. NEIGRIHMS is recruiting for a project manager job. MSc Life Science candidates are encouraged to attend the walk-in interview that has been scheduled, check out all of the details on the same below: Keep in mind: Applicants who wish to appear in […]

Related Post

  • BiotechToday
  • World

OAS1 p46 Sensor locating the hidden place of RNA viruses

bioxone August 19, 2021August 19, 2021

Husna, Amity University Kolkata How can RNA viruses be detected in a cell? Some species of RNA viruses have the ability to cover themselves, hide inside a cell, and create copies of themselves. Positive-strand RNA viruses like the SARS-CoV-2 virus, flaviviruses (West Nile and Zika), as well as picornaviruses (cause polio and some heart and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Do oncogenic driver mutations cause squamous cell cancers?

bioxone October 9, 2020October 8, 2020

Saptaparna Pal, Amity University Kolkata Head and neck squamous cell carcinoma are one of the most common neoplasias in the world. Most head and neck squamous cell carcinoma are treated as advanced disease and the multidisciplinary treatment strategies include radiotherapy (RT), chemotherapy (CT), surgery, and selected therapy. The addition of cetuximab, an IgGI chimeric monoclonal […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 DRUGS: NOW OBTAINED FROM COMPUTATIONAL MODELLING

bioxone March 2, 2021March 1, 2021

Prama Ghosh, Amity University Kolkata A new mechanism to help scientists fight against COVID – 19 and find new treatments for the disease has been elaborated by a team of researchers at the University of Warwick. Movements in nearly 300 protein structures of the spike protein of the virus are simulated using computational modelling techniques, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy